Cargando…
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
Recently, low-dose ketamine has been proposed as a rapid-acting treatment option for suicidality. The majority of studies to date have utilised intravenous (IV) ketamine, however, this route of administration has limitations. On the other hand, oral ketamine can be administered in a range of setting...
Autores principales: | Can, Adem T., Hermens, Daniel F., Dutton, Megan, Gallay, Cyrana C., Jensen, Emma, Jones, Monique, Scherman, Jennifer, Beaudequin, Denise A., Yang, Cian, Schwenn, Paul E., Lagopoulos, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862447/ https://www.ncbi.nlm.nih.gov/pubmed/33542187 http://dx.doi.org/10.1038/s41398-021-01230-z |
Ejemplares similares
-
Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support
por: Beaudequin, Denise, et al.
Publicado: (2020) -
Oral ketamine may offer a solution to the ketamine conundrum
por: Dutton, Megan, et al.
Publicado: (2023) -
A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
por: Can, Adem T., et al.
Publicado: (2022) -
The effect of mindfulness training on resting-state networks in pre-adolescent children with sub-clinical anxiety related attention impairments
por: Kennedy, Michelle, et al.
Publicado: (2022) -
Spectral Changes of EEG Following a 6-Week Low-Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality
por: Anijärv, T E, et al.
Publicado: (2023)